Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - LONG-TERM DEBT
Long-term Debt DMAC - DiaMedica Therapeutics Inc.
317 K
LAST VALUE
626.87%
2 YEAR CAGR
54.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR